4Front Ventures Corp.
FFVWF
Other OTC0.30
USD
- -
- -
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
- -
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- Similar Companies
- Business
- 4Front Ventures Corp. (OTCQX: FFNTF) is a vertically integrated multi-state cannabis operator focused on the cultivation, processing, manufacturing, and retail sale of premium cannabis products in the United States. The company produces over 20 recreational brands encompassing approximately 1,800 SKUs of flower, edibles, tinctures, concentrates, vapes, topicals, and infused pre-rolls; it also offers CBD wellness products through its Pure Ratios brand and manufactures third-party brands such as Bloom Farms vapes, concentrates, tinctures, and topicals. 4Front Ventures operates cultivation, production, and Mission dispensary retail locations primarily in Illinois and Massachusetts, with facilities in Washington, manufacturing in California, and presence in Michigan; it distributes to its own retail outlets and third-party customers while leasing real estate and providing ancillary services in Washington. Founded in 2011 and headquartered in Phoenix, Arizona, the company manages operations across THC cannabis and CBD wellness segments, targeting adult-use and medical markets through wholesale, retail, and branded product channels. In recent developments, 4Front Ventures expanded cultivation capacity in Illinois to over 12,000 square feet of flowering canopy, opened a new Mission dispensary in Norridge, Illinois, and launched new product lines including solventless formulations, Island Mini infused pre-rolls, and enhanced offerings in Massachusetts and Illinois; it entered advanced discussions for bulk sales, private label partnerships, and long-term supply contracts while partnering with a leading cannabis marketing agency to boost brand recognition. The company reported Q2 2024 revenue of $18.7 million and adjusted EBITDA of $2.6 million, reflecting growth in wholesale demand and retail performance amid competitive markets; however, in 2025, its U.S. subsidiaries filed for voluntary court-appointed receivership proceedings in Massachusetts.